Population Pharmacokinetics and Pharmacodynamics of Cinaciguat, a Soluble Guanylate Cyclase Activator, in Patients with Acute Decompensated Heart Failure

Author： Mueck Wolfgang   Frey Reiner  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.2, 2010-02, pp. : 119-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble guanylate cyclase

By Hobbs A.J.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 6, 2000-12 ,pp. : 735-749

Informa Healthcare

Access to resources Recommend Favorite

Soluble guanylate cyclase: the forgotten sibling

By Hobbs A.J.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 12, 1997-12 ,pp. : 484-491

Elsevier

Access to resources Recommend Favorite

YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice

By Teng C.-M.   Wu C.-C.   Ko F.-N.   Lee F.-Y.   Kuo S.-C.  

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 161-166

Elsevier

Access to resources Recommend Favorite

Drug Treatment of Patients with Decompensated Heart Failure

By Mills R.M.   Hobbs R.E.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 119-125

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients

By >  

Clinical Pharmacokinetics, Vol. 50, Iss. 11, 2011-11 ,pp. : 739-750

Adis International

Access to resources Recommend Favorite